Skip to main content
. 2020 Mar 6;8(4):617–624. doi: 10.1002/ccr3.2636

Figure 1.

Figure 1

Clinical course of OSMM patient with LCE, showing FLC ratio, diagnostic and immunophenotypic images. A, MRI scan with coronal T1‐W and sagittal STIR sequences of the growing knee mass (1st EMD relapse). B, Dot plot shows the presence of plasma cells CD38 + CD138+, evaluated in cytometry, in extramedullary site. C, FLC curve in OS MM patient with EMD relapse following LCE during KRd therapy (OSMM—oligo‐secretory multiple myeloma; LCE—light chain escape; FLC I/U ratio—free light chain involved/uninvolved ratio (n.v. 0.31‐1.56); KRd—carfilzomib, lenalidomide, dexamethasone; EMD—extramedullary myeloma disease)